XML 29 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Business Segments
 9 Months Ended
Sep. 27, 2025
Segment Reporting [Abstract]  
Business Segments

13. Business Segments

The Company operates in one segment: ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27, 2025

 

 

September 28, 2024

 

 

September 27, 2025

 

 

September 28, 2024

 

Cyclo G6

 

$

3,537

 

 

$

3,127

 

 

$

10,012

 

 

$

9,416

 

Retina

 

 

6,698

 

 

 

6,450

 

 

 

21,390

 

 

 

20,519

 

Other(1)

 

 

2,249

 

 

 

2,004

 

 

 

6,549

 

 

 

6,038

 

Total revenues

 

$

12,484

 

 

$

11,581

 

 

$

37,951

 

 

$

35,973

 

 

(1) Includes service contract revenues of $0.4 million and $47 thousand, and $1.0 million and $0.4 million recognized during the three and nine months ended September 27, 2025 and September 28, 2024, respectively. Includes $0.4 million and $1.1 million recognized revenue related to the exclusive distribution rights during both of the three and nine months ended September 27, 2025 and September 28, 2024, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

 

Revenue information shown by geographic region, based on the sales destination, is as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27, 2025

 

 

September 28, 2024

 

 

September 27, 2025

 

 

September 28, 2024

 

United States

 

$

5,588

 

 

$

5,464

 

 

$

16,631

 

 

$

16,383

 

Europe, Middle East and Africa

 

 

4,033

 

 

 

2,802

 

 

 

10,547

 

 

 

9,167

 

Asia/Pacific Rim

 

 

2,066

 

 

 

2,708

 

 

 

9,101

 

 

 

8,750

 

Americas, excluding the U.S.

 

 

797

 

 

 

607

 

 

 

1,672

 

 

 

1,673

 

 

 

$

12,484

 

 

$

11,581

 

 

$

37,951

 

 

$

35,973

 

 

Revenues are attributed to countries based on the location of end customers.

Other than the United States, the Netherlands accounted for at least 10% of the Company’s revenues during the three and nine months ended September 27, 2025, representing 22.6% and 15.7%, respectively. Other than the United States, the Netherlands accounted for at least 10% of the Company’s revenues during the three and nine months ended September 28, 2024, representing 13.1% and 15.2%, respectively. The United States accounted for 44.8% and 47.2% of revenues for the three months ended September 27, 2025 and September 28, 2024, respectively, and 43.8% and 45.5% for the nine months ended September 27, 2025 and September 28, 2024, respectively.